PD-L1 is a diverse molecule regulating both tumor-intrinsic signaling and adaptive immunosuppression

Podobne zapisy

• Cell genomics and immunosuppressive biomarker expression influence PD-L1 immunotherapy treatment responses in HNSCC - a computational study
  od: Bates, Amber M., i wsp.
  Wydane: (2017)
• Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
  od: Yang, Li, i wsp.
  Wydane: (2019)
• Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
  od: Brogden, Kim A., i wsp.
  Wydane: (2018)
• Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy
  od: Brogden, Kim A., i wsp.
  Wydane: (2018)
• Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
  od: Yunzhou Pu, i wsp.
  Wydane: (2022-05-01)